NRP1 and neoplasm: A better understanding of NRP-1 contribution to intracellular signal transduction mechanisms and the design of molecules that impair the binding of specific ligands, involved in tumor progression, will provide additional opportunities for the development of new therapeutic approaches to target NRP-1 in melanoma and to limit systemic toxicity.